Med. praxi. 2014;11(5):226-230

Serotinin syndrome: what we should know about it

MUDr.Michal Prokeš, PharmDr.Josef Suchopár
Infopharm a.s., Praha

Serotonin syndrome is a rare potentially life-threatening condition, which is caused by drugs with serotoninergic aktivity. It is characterized

by mental status changes, autonomic instability and neuromuscular hyperactivity. Patients with moderate and severe cases of

serotonin toxicity require hospitalisation. Diagnostic problems are documented by several case reports published in medical literature, the

diagnostic criteria are explained and the list of drugs which can cause the serotonin syndrome is presented in this article.

Keywords: seroninin syndrome, drug interactions, SSRI antidepressants

Published: September 10, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Prokeš M, Suchopár J. Serotinin syndrome: what we should know about it. Med. praxi. 2014;11(5):226-230.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ables AZ, Nagubilli R. Prevention, diagnosis and management of serotonin syndrome. Am Fam Physician 2010; 81: 1139-1142. Go to PubMed...
    2. Rastogi R, Swarm RA, Patel TA. Case scenario: Opioid association with serotonin syndrome. Implication to the practitioners. Anaesthesiology 2011; 115: 1291-1298. Go to original source... Go to PubMed...
    3. Verre M, Bossio F, Mammone A, et al. Serotinin syndrome caused by olanzapine and clomipramine. Minerva Anestesiol 2008; 74: 41-45. Go to PubMed...
    4. Attar-Herzberg D, Apel A, Gang N, et al. The serotonin syndrome: Initial misdiagnosis. Isr Med Assoc J 2009; 11: 367-370. Go to PubMed...
    5. Kulkarni RR, Kulkarni PR. Linezolid-induced near-fatal serotonin syndrom during escitalopram therapy: Case report and review of literature. Indian J Psychol Med 2013; 35: 413-416. Go to original source... Go to PubMed...
    6. Perry NK. Venlafaxin-induced serotonin sydnrome with relapse following amitriptyline. Postgrad Med 2000; 76: 254-256. Go to original source... Go to PubMed...
    7. Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. Q J Med 2003; 96: 635-642. Go to original source... Go to PubMed...
    8. Berman BD. Neuroleptic malignat syndrome: A review for neurohospitalists. Neurohospitalist, 2011; 1: 41-47. Go to original source... Go to PubMed...
    9. Khali S, Kornreich C, Choubani Z, et al. Neuroleptic malignant syndrome and atypical antipsychotics: a brief review. Encephale 2008; 34: 618-624. Go to original source... Go to PubMed...
    10. Isbister GK, Buckley NA, Whyte IM. Serotonin toxicity: a practical approach to diagnosis and treatment. Medical Journal of Australia 2007; 187: 361-365. Go to original source... Go to PubMed...
    11. Stockley´s Drug Interactions, 10th Edition, Pharmaceutical Press 2013: 13-15.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.